The Possible Role of Quinolones in Yersiniosis
- 1 January 1987
- journal article
- Published by Springer Nature in Drugs
- Vol. 34 (Supplement), 134-138
- https://doi.org/10.2165/00003495-198700341-00029
Abstract
The in vitro susceptibility of 135 strains of Yersinia enterocolitica was tested by agar dilution. About 85% of the strains were susceptible to trimethoprim (1 mg/L), tetracycline (4 mg/L), chloramphenicol (4 mg/L) and cefuroxime (8 mg/L); 90 to 100% to piperacillin (16 mg/L), cefotaxime (8 mg/L) and gentamicin (1 mg/L); 100% to ciprofloxacin (≤ 0.016 mg/L), ofloxacin (0.06 mg/L) and pefloxacin (0.12 mg/L). The outcome of 88 patients, treated for various forms of yersiniosis, showed 15% failure for trimethoprim or co-trimoxazole and tetracycline and 70% failure for cephalosporins and aminoglycoside-β-lactam combinations. Four patients were successfully treated with ciprofloxacin 500mg orally or 300mg intravenously administered twice daily for up to 6 weeks.Keywords
This publication has 7 references indexed in Scilit:
- Incidence of human infection with Yersinia enterocolitica serotypes O3, O8, and O9 and the use of indirect immunofluorescence in diagnosis.1986
- In-vitro activity of newer quinolones against aerobic bacteriaJournal of Antimicrobial Chemotherapy, 1986
- Intraprostatic concentration of ciprofloxacin and its activity against urinary pathogensJournal of Antimicrobial Chemotherapy, 1984
- Yersinia enterocolitica: Guidelines for Serologic Diagnosis of Human InfectionsClinical Infectious Diseases, 1983
- Yersinia enterocolitica PharyngitisAnnals of Internal Medicine, 1983
- The susceptibility of Yersina to eleven antimicrobialsJournal of Antimicrobial Chemotherapy, 1982
- In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution methodEuropean Journal of Clinical Microbiology & Infectious Diseases, 1982